國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 914139      在线人数 : 1295
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版
    圖書 [1/1]
    期刊論文 [327/330]

    类别统计

    近3年内发表的文件:16(8.94%)
    含全文笔数:115(64.25%)

    文件下载次数统计
    下载大于0次:115(100.00%)
    下载大于100次:112(97.39%)
    全文下载总次数:39325(22.06%)

    最后更新时间: 2024-12-01 10:33


    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目151-175 / 179. (共8页)
    << < 1 2 3 4 5 6 7 8 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2009-12 A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157.
    2009-10 Pharmacoeconomic analysis of capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) in the first line treatment of metastasis colorectal cancer in Taiwan Value in Health. 2009 Oct;12(7):A278.
    2009-09 Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors EJC Supplements. 2009 Sep;7(3):16.
    2009-05-20 Differential response of primary or secondary exon 13/14 and exon 17 c-kit mutant to nilotinib and sunitinib: Findings from a cell-based drug-screening platform Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15636.
    2009-05-20 A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562.
    2009-05-20 Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number e19512.
    2009-05-20 Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
    2009-05 RAD001 (everolimus) suppresses growth of a gastric MALT lymphoma cell Line via downregulation of pAKT/mTOR and BAFF/NF-\#954;B signal transduction pathways Cancer Research. 2009 May;69:Abstract number 2762.
    2009 Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis Annals of Oncology. 2009;20(Suppl. 7):91.
    2008-05 Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan Value in Health. 2008 May-Jun;11(3):A64-A65.
    2008-05 Pharmacoeconomic analysis of capecitabine for advanced gastric cancer in Taiwan Journal of Clinical Oncology. 2008 May;26(15):Abstract number 15576.
    2008-05 Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610.
    2008 Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment Journal of Hepatology. 2008;48(Suppl. 2):S145-S146.
    2007-09 A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer EJC Supplements. 2007 Sep;5(4):268.
    2007-06 H pylori-positive gastric diffuse large B-cell lymphomas are potentially curable by H pylori eradication therapy Journal of Clinical Oncology. 2007 Jun;25(18, Suppl.):Meeting Abstract 8093.
    2007-05 Pharmacoeconomic analysis of capecitabine in adjuvant treatment of stage III colon cancer in Taiwan Value in Health. 2007 May-Jun;10(3):A11-A12.
    2006-11 Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity EJC Supplements. 2006 Nov;4(12):59.
    2005-06 An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report Journal of Clinical Oncology. 2005 Jun;23(16):Abstract number 346S.
    2004-08-02 Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer British Journal of Cancer. 2004 Aug;91(3):453-458.
    2004-08 Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma Haematologica. 2004 Aug;89(8):1015-1017.
    2004-07 Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC) Journal of Clinical Oncology. 2004 Jul;22(14):Abstract number 362S.
    2004-06 Acute hemorrhagic rectal ulcer syndrome: A new clinical entity? Report of 19 cases and review of the literature Diseases of the Colon and Rectum. 2004 Jun;47(6):895-903.
    2003-11 Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma Cancer Epidemiology Biomarkers & Prevention. 2003 Nov;12(11):1288S.
    2002-11 Expression of nuclear BCL10 is highly correlated with the expression of nuclear NF-kB and is predictive of Helicobacter pylori-dependent status in early-stage high-grade gastric MALT lymphoma European Journal of Cancer. 2002 Nov;38(Suppl. 7):S162.
    2002 Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma International Journal of Cancer. 2002;Suppl. 13:336-337.

    显示项目151-175 / 179. (共8页)
    << < 1 2 3 4 5 6 7 8 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈